Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests. The findings – published recently in the Journal of Clinical Oncology – suggest that stem cell transplants offer long-term benefits for young patients who get CAR T-cell therapy, according to the University of Virginia researchers.